US-based medical technology firm PulsePoint has significantly expanded its programmatic electronic health record (EHR) reach within numerous leading US health systems.
The expansion allows brands to connect with healthcare professionals (HCPs) at crucial point-of-care moments, making PulsePoint one of the largest providers of EHR scale.
Life science brands can now utilise PulsePoint’s advanced technology and comprehensive data to engage over 700,000 prescribers across ambulatory and health system settings.
The engagement occurs directly within the clinical workflow and extends across various channels over time, enhancing brand interaction with a diverse HCP user base.
The expanded EHR access enables brand engagement by reaching a broader spectrum of HCPs, including those in acute, speciality, post-operative, and long-term chronic settings.
PulsePoint group sales vice president Keith Matt said: “It’s not surprising that the ability to engage with HCPs via EHRs has become some of the most sought-after inventory on our platform.
“HCPs spend an average of four to five hours a day in their EHR, making it a highly valuable touchpoint for brand engagement.”
Brands using PulsePoint’s platform can integrate their EHR purchases across multiple systems, creating a unified strategy with advanced targeting and synchronised messaging.
PulsePoint addresses longstanding challenges in EHR marketing by offering detailed campaign reporting on all National Provider Identifiers (NPIs) reached.
The platform provides granular daily metrics and real-time clinical insights, allowing users to refine creative strategies and drive script lift during provider-patient consultations.
Internet Brands growth platforms EVP Konrad Gerszke said: “PulsePoint has redefined what’s possible in EHR advertising.
“We offer unmatched scale, sophisticated data-driven HCP engagement, seamless omnichannel integration, and real-time campaign insights and optimisation, making us the most complete partner in the space.
“Most importantly, we’ve seen these capabilities translate to measurable impact on brand-prescribing behaviours.”
